《新股消息》易點雲(02416.HK)今起招股 一手入場費6,061元
內地辦公IT綜合解決方案供應商易點雲(02416.HK)公布招股詳情,擬全球發售5,857.5萬股,香港公開發售佔一成,國際發售佔九成,每股招股價介乎10至12元。每手500股計,一手入場費6,060.51元。該股今日(15日)起招股,周四(18日)中午截止,預期下周四(25日)掛牌。獨家保薦人為中金公司。
公司上市引入策源投資為基石投資者,認購1,997萬美元公司股份。
如以招股價中位數11元計,公司上市料淨集資約1.11億元,將於未來三年內,將約40%分配以提高銷售及營銷能力及擴大服務網絡;約30%用於優化及擴大服務內容;約20%用於增強再製造能力;約10%用作營運資金及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.